Cancer screening options are important to older adults

New York, NY and Menlo Park, CA, April 07, 2025 — A recent survey, conducted by Ipsos among U.S. adults ages 50-75, explored attitudes toward cancer screenings. The survey, conducted on behalf of GRAIL, shows there is a broad desire among adults ages 50-75 to learn more about cancer screening options from their healthcare provider. As a majority of individuals surveyed think early detection is important, most expect their providers to offer the latest cancer screening technologies, regardless of perceptions of patient affordability.

For U.S. adults ages 50-75 surveyed, key findings* include:

1. 9 out of 10 would want to know if they have cancer as early as possible so they could take action.
2. Nearly 8 out of 10 expect their healthcare providers to offer the latest cancer screening technologies, regardless of perceived ability to pay.
3. Nearly 9 out of 10 would want their healthcare provider to make them aware of Multi-Cancer Early Detection (MCED) tests.
4. 8 out of 10 believe the Galleri test is on the forefront of the latest cancer screening technologies.

The study also looked at subsets of this audience, including those who had a family history of cancer or were cancer survivors. These audiences had even higher expectations (81-88%, respectively) for their HCP “to offer the latest cancer screening technologies, regardless of whether they believe I am able to pay for them.”

*Findings are based on the percentage of respondents selecting “somewhat agree” or “strongly agree” with each statement.

About the Study

GRAIL survey, with data collection by Ipsos: n=1,000 US adults aged 50-75, fielded online between August 12 and 21, 2024. Sample was weighted to reflect U.S. Census data (for Americans aged 50-75) on age, gender, race/ethnicity, income, and region. The sample has a credibility interval, a measure of precision for online polls, of plus or minus 3.8 percentage points.

Source: GRAIL survey of n=1,000 US adults aged 50-75, conducted by Ipsos, August 12-21, 2024

About Ipsos

Ipsos is one of the largest market research and polling companies globally, operating in 90 markets and employing over 18,000 people.

Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. Our 75 solutions are based on primary data from our surveys, social media monitoring, and qualitative or observational techniques.

Our tagline "Game Changers" sums up our ambition to help our 5,000 customers move confidently through a rapidly changing world.

Founded in France in 1975, Ipsos has been listed on the Euronext Paris since July 1, 1999. The company is part of the SBF 120 and Mid-60 indices and is eligible for the Deferred Settlement Service (SRD).ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP